401 related articles for article (PubMed ID: 26327129)
1. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
2. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
Smoczynski M; Jablonska A; Matyskiel A; Lakomy J; Dubowik M; Marek I; Biernat W; Limon J
Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
[TBL] [Abstract][Full Text] [Related]
3. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
Zhai J
Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
[TBL] [Abstract][Full Text] [Related]
4. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.
Fritcher EG; Kipp BR; Halling KC; Oberg TN; Bryant SC; Tarrell RF; Gores GJ; Levy MJ; Clayton AC; Sebo TJ; Roberts LR
Gastroenterology; 2009 Jun; 136(7):2180-6. PubMed ID: 19232347
[TBL] [Abstract][Full Text] [Related]
5. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
6. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
7. Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.
Kipp BR; Barr Fritcher EG; Pettengill JE; Halling KC; Clayton AC
Cancer Cytopathol; 2013 Nov; 121(11):610-9. PubMed ID: 23633236
[TBL] [Abstract][Full Text] [Related]
8. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.
Barr Fritcher EG; Kipp BR; Halling KC; Clayton AC
Cytopathology; 2014 Oct; 25(5):288-301. PubMed ID: 25073411
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
10. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.
Barr Fritcher EG; Caudill JL; Blue JE; Djuric K; Feipel L; Maritim BK; Ragheb AA; Halling KC; Henry MR; Clayton AC
Am J Clin Pathol; 2011 Sep; 136(3):442-9. PubMed ID: 21846921
[TBL] [Abstract][Full Text] [Related]
11. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis: A better FISH to detect pancreatobiliary cancer?
Patman G
Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):551. PubMed ID: 26369313
[No Abstract] [Full Text] [Related]
13. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures.
Moreno Luna LE; Kipp B; Halling KC; Sebo TJ; Kremers WK; Roberts LR; Barr Fritcher EG; Levy MJ; Gores GJ
Gastroenterology; 2006 Oct; 131(4):1064-72. PubMed ID: 17030177
[TBL] [Abstract][Full Text] [Related]
14. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography.
Kipp BR; Fritcher EG; Clayton AC; Gores GJ; Roberts LR; Zhang J; Levy MJ; Halling KC
J Mol Diagn; 2010 Nov; 12(6):780-6. PubMed ID: 20864634
[TBL] [Abstract][Full Text] [Related]
15. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
Liew ZH; Loh TJ; Lim TKH; Lim TH; Khor CJL; Mesenas SJ; Kong CSC; Ong WC; Tan DMY
J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
[TBL] [Abstract][Full Text] [Related]
16. Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology.
Vlajnic T; Somaini G; Savic S; Barascud A; Grilli B; Herzog M; Obermann EC; Holmes BJ; Ali SZ; Degen L; Bubendorf L
Cancer Cytopathol; 2014 Aug; 122(8):627-34. PubMed ID: 24753508
[TBL] [Abstract][Full Text] [Related]
17. An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy.
Pu X; Zheng H; Yang X; Ye Q; Fan Z; Yang J; Fan X; Zhou X; Qiu Y; Huang Q; Wu H; Chen J
BMC Gastroenterol; 2020 Nov; 20(1):367. PubMed ID: 33148183
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
19. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
20. Refined pancreatobiliary UroVysion criteria and an approach for further optimization.
Mettman D; Saeed A; Shold J; Laury R; Ly A; Khan I; Golem S; Olyaee M; O'Neil M
Cancer Med; 2021 Sep; 10(17):5725-5738. PubMed ID: 34374212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
